Literature DB >> 8608690

Subacute cutaneous lupus erythematosus associated with Hodgkin's disease.

J Castanet1, B Taillan, J P Lacour, G Garnier, C Perrin, J P Ortonne.   

Abstract

Simultaneous occurrence of subacute cutaneous lupus erythematosus and malignancy has rarely been reported. We report the first case of subacute cutaneous lupus erythematosus associated with Hodgkin's disease. Although our case does not fulfill the criteria of paraneoplastic process, a relationship between the two disorders might be suggested by their simultaneous occurrence and in view of the cases of disseminated lupus erythematosus associated with lymphoma reported so far. The different hypotheses are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 8608690     DOI: 10.1007/bf02207938

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

Review 1.  Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.

Authors:  E Zappi; R Sontheimer
Journal:  Clin Dermatol       Date:  1992 Oct-Dec       Impact factor: 3.541

2.  Disappearance of clinical and biological evidence of SLE after removal of an ovarian seminoma: 21 years' followup.

Authors:  M F Kahn; J Solnica; P Bourgeois
Journal:  J Rheumatol       Date:  1986-08       Impact factor: 4.666

Review 3.  Immunodeficiency and the pathogenesis of lymphoma and leukemia.

Authors:  S Louie; R S Schwartz
Journal:  Semin Hematol       Date:  1978-04       Impact factor: 3.851

4.  Malignancy in a series of 70 patients with systemic lupus erythematosus.

Authors:  J J Canoso; A S Cohen
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

5.  Malignant lymphoma and acute SLE.

Authors:  A G Cudworth; A Ellis
Journal:  Br Med J       Date:  1972-07-29

6.  Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.

Authors:  R D Sontheimer; J R Thomas; J N Gilliam
Journal:  Arch Dermatol       Date:  1979-12

7.  Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients.

Authors:  J P Callen; J Klein
Journal:  Arthritis Rheum       Date:  1988-08

8.  The association of malignancy with SLE: an analysis of 150 patients under long-term review.

Authors:  S Menon; M L Snaith; D A Isenberg
Journal:  Lupus       Date:  1993-06       Impact factor: 2.911

9.  Subacute cutaneous lupus erythematosus associated with breast carcinoma.

Authors:  M Schewach-Millet; D Shpiro; R Ziv; H Trau
Journal:  J Am Acad Dermatol       Date:  1988-08       Impact factor: 11.527

10.  Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  R B Lewis; C W Castor; R E Knisley; G G Bole
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec
View more
  2 in total

1.  IgG deposits can be detected in cell nuclei of patients with both lupus erythematosus and malignancy.

Authors:  Ingrid Böhm
Journal:  Clin Rheumatol       Date:  2007-03-16       Impact factor: 2.980

Review 2.  Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.

Authors:  Roberto Maglie; Giovanni Genovese; Farzan Solimani; Alba Guglielmo; Alessandro Pileri; Francesca Portelli; Michael Hertl; Angelo Valerio Marzano; Emiliano Antiga
Journal:  Am J Clin Dermatol       Date:  2020-12       Impact factor: 7.403

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.